227 related articles for article (PubMed ID: 15121805)
1. Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice.
Pacher P; Bátkai S; Kunos G
J Physiol; 2004 Jul; 558(Pt 2):647-57. PubMed ID: 15121805
[TBL] [Abstract][Full Text] [Related]
2. The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor.
Williams MA; Smith SA; O'Brien DE; Mitchell JH; Garry MG
J Physiol; 2008 Feb; 586(3):835-45. PubMed ID: 18063665
[TBL] [Abstract][Full Text] [Related]
3. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
Malinowska B; Kwolek G; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.
Pacher P; Bátkai S; Osei-Hyiaman D; Offertáler L; Liu J; Harvey-White J; Brassai A; Járai Z; Cravatt BF; Kunos G
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H533-41. PubMed ID: 15821037
[TBL] [Abstract][Full Text] [Related]
5. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.
de Lago E; de Miguel R; Lastres-Becker I; Ramos JA; Fernández-Ruiz J
Brain Res; 2004 May; 1007(1-2):152-9. PubMed ID: 15064146
[TBL] [Abstract][Full Text] [Related]
6. The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder.
Saitoh C; Kitada C; Uchida W; Chancellor MB; de Groat WC; Yoshimura N
Eur J Pharmacol; 2007 Sep; 570(1-3):182-7. PubMed ID: 17586490
[TBL] [Abstract][Full Text] [Related]
7. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.
Domenicali M; Ros J; Fernández-Varo G; Cejudo-Martín P; Crespo M; Morales-Ruiz M; Briones AM; Campistol JM; Arroyo V; Vila E; Rodés J; Jiménez W
Gut; 2005 Apr; 54(4):522-7. PubMed ID: 15753538
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of pulmonary vagal C-fibres by anandamide in anaesthetized rats: role of vanilloid type 1 receptors.
Lin YS; Lee LY
J Physiol; 2002 Mar; 539(Pt 3):947-55. PubMed ID: 11897863
[TBL] [Abstract][Full Text] [Related]
10. The contribution of VR1 and CB1 receptors and the role of the afferent vagal pathway in modelling of cardio-respiratory effects of anandamide in rats.
Kopczyńska B
Life Sci; 2007 Apr; 80(19):1738-45. PubMed ID: 17379256
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
Lam FF; Luk PW; Ng ES
Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
[TBL] [Abstract][Full Text] [Related]
12. Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized rat.
Smith PJ; McQueen DS
Br J Pharmacol; 2001 Oct; 134(3):655-63. PubMed ID: 11588121
[TBL] [Abstract][Full Text] [Related]
13. Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats.
Kwolek G; Zakrzeska A; Schlicker E; Göthert M; Godlewski G; Malinowska B
Br J Pharmacol; 2005 Jul; 145(5):567-75. PubMed ID: 15834445
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular pharmacology of anandamide.
Högestätt ED; Zygmunt PM
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):343-51. PubMed ID: 12052048
[TBL] [Abstract][Full Text] [Related]
15. A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats.
Zakrzeska A; Schlicker E; Baranowska M; Kozłowska H; Kwolek G; Malinowska B
Br J Pharmacol; 2010 Jun; 160(3):574-84. PubMed ID: 20105178
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
[TBL] [Abstract][Full Text] [Related]
17. Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids.
Lam PM; McDonald J; Lambert DG
Br J Anaesth; 2005 May; 94(5):649-56. PubMed ID: 15722382
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons.
Singh Tahim A; Sántha P; Nagy I
Neuroscience; 2005; 136(2):539-48. PubMed ID: 16198486
[TBL] [Abstract][Full Text] [Related]
19. TRPV1, TRPA1, and CB1 in the isolated vagus nerve--axonal chemosensitivity and control of neuropeptide release.
Weller K; Reeh PW; Sauer SK
Neuropeptides; 2011 Dec; 45(6):391-400. PubMed ID: 21868092
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
